IPO

The company said it plans to list its stock on the Nasdaq under the ticker symbol GH.

The company's offering of 3.36 million units at $6.125 per unit — each consisting of one share of common stock and one warrant — is expected to close Aug. 23.

The company plans to offer nearly 2.5 million units at a price of $6.00 to $7.00 per unit, which at the midpoint of the range would raise about $16 million.

The center is an international joint venture established in 2013 between South Korean clinical lab Eone Life Science and California-based Diagnomics.

In 2017, Bionano had $9.5 million in revenues and a net loss of 23.4 million, or $7.66 per share.

The newly independent firm will continue to invest in diagnostics by bringing its menu of PCR tests for infectious diseases to the US and other markets, among other objectives.

The firm said it will use the net proceeds for R&D, including the continued development of its Acuitas AMR gene panels.

The firm sold more than 4.9 million shares of common stock at $15 per share, raising $73.7 million to expand its commercial operations and grow its technology.

Quanterix Plans IPO

The firm plans to use the proceeds to expands its commercial operations, expand its existing technology, and support the launch of its new platform.

Calyxt increased the number of shares it intends to float, but slashed its offering price in half from the middle of a previously disclosed range.

Pages

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.